Keyphrases
Atopic Dermatitis
100%
Infantile Hemangioma
75%
Endothelial Cells
61%
Pediatric Patients
58%
Melanoma
48%
Psoriasis
47%
Melanoma Cells
43%
Hemangioma
40%
Cutaneous Leishmaniasis
38%
Israel
37%
Methotrexate
36%
Pediatric Population
36%
Tumor
36%
Stem Cells
36%
Pediatric
35%
Systemic Administration
34%
Melanosome
34%
Sirolimus
34%
Clinical Characteristics
32%
Leishmania Tropica
31%
Whole Exome Sequencing
30%
Endothelin-1 (ET-1)
29%
Lung Metastasis
29%
Mastocytosis
27%
Angiogenesis
27%
Apoptosis
24%
Vascular Endothelial Growth Factor
24%
MicroRNA
24%
Immunodeficiency
24%
Novel mutation
23%
Vascular Wall
23%
Keratinocytes
23%
Pemphigus
23%
Transdifferentiation
23%
NRAS mutation
23%
Tuberous Sclerosis
23%
Chronic Urticaria
23%
Tuberous Sclerosis Complex
23%
Herpes Simplex Virus Thymidine Kinase
23%
Graft-versus-host Disease (GvHD)
23%
Double-stranded RNA
23%
RNA Editing
23%
Lymphatic Malformation
23%
Single-center Experience
23%
Multicenter Retrospective Study
23%
Gene Therapy
21%
Metastasis
21%
Corticosteroids
21%
Antiangiogenic
20%
Clinical Presentation
20%
Medicine and Dentistry
Pediatrics
92%
Diseases
60%
Retrospective Study
59%
Neoplasm
55%
Melanoma
54%
Pediatrics Patient
53%
Capillary Hemangioma
51%
Hemangioma
47%
Rapamycin
46%
Atopic Dermatitis
45%
Cutaneous Leishmaniasis
39%
Stem Cell
37%
Promoter Region
37%
Endothelial Cell
35%
Urticaria
34%
Melanoma Cell
34%
Exome Sequencing
30%
Mastocytosis
30%
Systemic Therapy
29%
In Vitro
28%
Chronic Urticaria
27%
Disease Course
27%
Infection
27%
Metastatic Carcinoma
26%
Congenital Malformation
26%
Melanosome
26%
microRNA
24%
Topical Treatment
24%
Psoriasis
24%
Angiogenesis
24%
Vascular Bundle
23%
Pemphigus
23%
Primary Tumor
23%
Herpes Simplex Virus
23%
Tuberous Sclerosis
23%
Leishmania tropica
23%
Thymidine Kinase
23%
Systemic Administration
23%
Lymphangiomatosis
23%
Systematic Review
23%
Immune Deficiency
23%
Lymph Duct
20%
Side Effect
20%
Lymphatic Anomaly
19%
Colony Forming Cell
19%
Mast Cell
18%
Leishmania Major
18%
Dermatitis
18%
Hormone Determination
17%
Mesenchymal Stem Cell
17%